European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 733-737 , September 2006

Axillary staging in women with small invasive breast tumours

  • G.Q. della Rovere

      Affiliations

    • Department of Surgery, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK
    • ,
  • R. Bonomi

      Affiliations

    • Department of Surgery, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK
    • ,
  • S. Ashley

      Affiliations

    • Department of Surgery, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK
    • ,
  • J.R. Benson

      Affiliations

    • Cambridge Breast Unit, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1223 216015; fax: +44 1223 586932.

,Accepted 20 April 2006.

References 

  1. Carter CL, Allen C, Henderson DE. Relation of tumour size, lymph node status and survival in 24,740 breast cancer cases. Cancer. 1989;73:505–508
  2. Early Breast Cancer Trialists Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet. 1998;352:930–942
  3. Macmillan RD, Blamey RW. The case for axillary sampling. Adv Breast Cancer. 2004;1:9–10
  4. Goyal A, Mansel RE. Sentinel lymph-node biopsy in breast cancer: facts and controversies. Adv Breast Cancer. 2004;1:11–15
  5. Mansel R. Sentinel node biopsy versus standard axillary treatment: results of the randomized multicenter UK ALMANAC Trial. Breast Cancer Res Treat. 2004;88:S13
  6. Querci della Rovere G, Benson JR. The case for axillary dissection. Adv Breast Cancer. 2004;1:3–8
  7. Viale G, Bosari S, Mazzarol G, et al. Intra-operative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer. 1999;85:2433–2439
  8. Fisher B, Redmond C, Fisher ER, et al. Ten year results of randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674–681
  9. McKinna F, Gothard L, Ashley S, Ebbs S, Yarnold J. Selective avoidance of lymphatic radiotherapy in the conservative management of women with early breast cancer. Radiother Oncol. 1999;52:219–223
  10. Epstein RJ. Routine or delayed axillary dissection for primary breast cancer?. Eur J Cancer. 1995;31A:1570–1573
  11. Greco M, Agresti R, Cascinella N, et al. Breast cancer patients treated without axillary surgery. Ann Surg. 2000;232:1–7
  12. Abner AL, Collins L, Peiro G, Recht A. Correlation of tumour size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer. 1998;83:2502–2508
  13. Silverstein M, Gierson E, Waisman J, Senofsky GM, Colburn W, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma: is it indicated?. Cancer. 1994;73:664
  14. Rosen PP, Groshen S, Saigo PE, Kinne D, Hellman S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N0M0) breast carcinomas: a study of 644 patients with median follow up of 18 years. J Clin Oncol. 1989;7:1239–1251
  15. Reger V, Beito G, Jolly PC. Factors affecting the incidence of incidence of lymph node metastases in small cancers of the breast. Am J Surg. 1989;157:501–502
  16. Steirer M, Rosen HR, Weber R, Marczell A, Kornek GV, Czerwenka E. Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter. Surg Gynaecol Obstet. 1992;175:151–160
  17. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murthy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980;45:2917–2924
  18. Bland KI. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas (invited commentary). J Am Coll Surg. 2000;191:6–8
  19. Saiz E, Toonkel R, Poppiti RJ, Robinson MJ. Infiltrating breast carcinoma smaller than 0.5 centimeters. Cancer. 1999;85:2206–2211
  20. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinomas. Cancer. 1997;79:1918–1922
  21. Maibenco DC, Weiss LK, Pawlish KS, Severson RF. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer. 1999;85:1530–1536
  22. Mustafa I, Bland K, Chang H. Prognostic analysis of survival in small breast cancers. J Am Coll Surg. 1998;186:562–563
  23. Rivadeneira DE, Simmons R, Christos PJ, Hanna K, Daly JM, Osborne MP. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: Analysis of more than 900 patients. J Am Coll Surg. 2000;191:1–6
  24. www.adjuvantonline.com
  25. International (Ludwig) Breast Cancer Study Group . Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565–1568
  26. Cady B. A contemporary view of axillary dissection (Editorial). Ann Surg. 2000;232:8–9
  27. Rietman JS, Dijkastra PU, Geertzen JH, Baas P, de Vries J, Dolsma W. Short-term morbidity of the upper limb after sentinel node biopsy or axillary lymph node dissection for stage I or 2 breast carcinoma. Cancer. 2003;98:690–696
  28. Sener SF, Winchester DJ, Martz CH, et al. Lymphoedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748–752
  29. Julian TB, Krag D, Brown A, et al. Preliminary technical results of NSABP B32, a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node negative breast cancer patients. Breast Cancer Res Treat. 2004;(Suppl. 1):83;Abstract 14 S11
  30. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg. 1986;73:580–584
  31. Querci della Rovere G, Ahmad I, Singh P, Ashley S, Daniels IR, Mortimer P. An audit of the incidence of arm lymphoedema after prophylactic lever I/II axillary dissection without division of the pectoralis minor muscle. Ann R Coll Surg Engl. 2003;85:158–161
  32. Cabanes PA, Salamon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet. 1992;339:1245–1248
  33. White RE, Vezeridis MP, Konstadoulakis M, et al. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg. 1996;183:575–582
  34. Querci della Rovere G, Benson JR. The biological significance of ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis. Lancet Oncol. 2002;3:45–49

PII: S0748-7983(06)00180-6

doi: 10.1016/j.ejso.2006.04.016

European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 733-737 , September 2006

Article Tools